Last edition
News about
Full-Life Technologies to Build GMP Radiopharmaceuticals Mfg. Facility
This strategic investment will enhance radiopharmaceutical production capabilities at a key logistical hub to ensure the timely supply and delivery worldwide.
PharmaKure and UiTM Collaborate for Advance Research in Alzheimer's Disease Diagnosis
The partnership is focused on advancing research initiatives on the use of machine learning tools to predict Alzheimer’s Disease using blood via academic-industry partnerships.
US Pharma Start-Up to Manufacture Artificial Retina in Space
The company LambdaVision will use the microgravity environment on the International Space Station (ISS) to develop a synthetic retinal implant that will restore sight to humans with degenerative eye diseases.<br />
Chinese Company to Set Up Pharmaceutical Ingredients Factory in BEPZA EZ
Chinese company Crescent Hi Tech Co. Ltd. is going to set up an ‘Active Pharmaceutical Ingredients (API)’ manufacturing industry in BEPZA Economic Zone.
SEQSTER Launches CoRD Accelerating Drug Discovery and Deep Insights for Pharma
This innovative tool parses, standardizes, and transforms data into a clean, common form, eliminating barriers to comprehensive healthcare insights.
Vanda Pharmaceuticals Acquires US and Canadian Rights to PONVORY
Vanda Pharmaceuticals Inc. (Vanda) announced that it has acquired US and Canadian rights to PONVORY® (ponesimod) from Actelion Pharmaceuticals Ltd. (Janssen), a Johnson & Johnson Company.
Natco Pharma Chennai Plant Operations Disrupted Due To Cyclone
After following the required step process and safety measures, the factory operations have been shut down temporarily, the drug firm said in a regulatory filing.
C-CAR031 is based on a novel GPC3-targeting CAR-T (AZD5851) designed by AstraZeneca using their transforming growth factor-beta receptor II (TGFβRII) dominant negative armoring discovery platform, and is manufactured by AbelZeta in China.
Dr. Reddy's Laboratories Gets 3 Observations from USFDA for R&D Centre
The company has been issued a Form 483 with three observations, which we will address within the stipulated timeline.
Sanofi and Minapharm Sign Agreement for Localizing Manufacture of Clexane
Sanofi and Minapharm announce the signing of an exclusive Manufacturing and Supply Agreement for the localization of the full range of its flagship market leader product, Clexane®.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy